Agios Pharmaceuticals Inc (AGIO) concluded trading on Wednesday at a closing price of $58.66, with 0.45 million shares of worth about $26.3 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 56.26% during that period and on November 27, 2024 the price saw a loss of about -0.74%. Currently the company’s common shares owned by public are about 55.95M shares, out of which, 55.13M shares are available for trading.
Stock saw a price change of 7.40% in past 5 days and over the past one month there was a price change of 25.26%. Year-to-date (YTD), AGIO shares are showing a performance of 163.40% which increased to 164.23% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $20.96 but also hit the highest price of $62.58 during that period. The average intraday trading volume for Agios Pharmaceuticals Inc shares is 570.19K. The stock is currently trading 8.41% above its 20-day simple moving average (SMA20), while that difference is up 21.72% for SMA50 and it goes to 43.89% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Agios Pharmaceuticals Inc (NASDAQ: AGIO) currently have 55.95M outstanding shares and institutions hold larger chunk of about 104.87% of that.
The stock has a current market capitalization of $3.35B and its 3Y-monthly beta is at 0.79. PE ratio of stock for trailing 12 months is 5.16, while it has posted earnings per share of $11.37 in the same period. It has Quick Ratio of 8.77 while making debt-to-equity ratio of 0.04. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for AGIO, volatility over the week remained 4.03% while standing at 4.99% over the month.
Stock’s fiscal year EPS is expected to rise by 281.41% while it is estimated to decrease by -152.92% in next year.
Coverage by Raymond James stated Agios Pharmaceuticals Inc (AGIO) stock as an Outperform in their note to investors on October 10, 2024, suggesting a price target of $51 for the stock. Stock get an Overweight rating from Piper Sandler on February 03, 2023.
